Indication : For the treatment of Type-2 Diabetes Mellitus.
Type 2 Diabetes mellitus a chronic condition that affects the way the body processes blood sugar.
MOA : Vildagliptin Inhibits dipeptidyl peptidase-4 (DPP-4), increasing incretin hormones (GLP-1 and GIP), which stimulate insulin release and decrease glucagon levels. Metformin activates AMPK and reduce hepatic glucose levels.
